Summary
Pharmacogenomics (PGx) focuses on how genes and biomarkers can affect how an individual respond to drugs. The goal of PGx is to develop effective, safe medications and doses that can be tailored to an individual's genetic makeup.
Register to download
PV Nugget #7 Pharmacogenomics
You may also be interested in:
Case Study
PRA Leads Novel Multiple Myeloma Drug Development
PRA Health Sciences supported 2 multiple myeloma clinical trials, a Phase III and a “rollover,” for a large biotech client. This management contract…
View Resource
Newsletter
Pharmacovigilance Nugget #3 The Challenges of Effective PSMF Maintenance - December 2018
The Pharmacovigilance System Master File (PSMF) is a legal requirement in the European Union (EU). A PSMF shall describe the pharmacovigilance (PV)…
View Resource
Webcast
Practical Implementation of Signal Detection in Iterative Benefit Risk Evaluation
This webcast with PRA Health Sciences' Jacinta Aniagolu-Johnson (Senior Director, Safety and Risk Management) explores how a well defined signal…
View Resource
View all related content and resources for Pharmacovigilance
Explore Insights